EMBARGOED TIPSHEET SABCS: Subgroup analysis of trastuzumab deruxtecan (T-DXd) shows ‘encouraging’ results in controlling stable brain metastases in HER2-positive metastatic ...
A type of cell transformation known as EMT enables cancer cells to break away from the tumor and form metastases ...
BOSTON – A targeted drug has shown promising activity against brain metastases resulting from kidney cancer, achieving a 50 percent ...
OCTOBER 18, 2021, NEW YORK – A Ludwig Cancer Research study has identified and preclinically validated combination treatments for the brain metastases ...
In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto, Canada, have demonstrated that magnetic resonance (MR)-guided ...
